Items where Author is "Brentville, V"

COOK, K., XUE, W., SYMONDS, P., DANIELS, I., GIJON, M., BOOCOCK, D., COVENEY, C., MILES, A., SHAH, S., ATABANI, S., CHOUDHURY, R., VAGHELA, P., WESTON, D., METHERINGHAM, R., BRENTVILLE, V. and DURRANT, L., 2021. Homocitrullination of lysine residues mediated by myeloid derived suppressor cells in the tumour environment is a target for cancer immunotherapy. Journal for ImmunoTherapy of Cancer, 9 (7): e001910.

ALMSHAYAKHCHI, R., NAGARAJAN, D., VADAKEKOLATHU, J., GUINN, B.-A., REEDER, S., BRENTVILLE, V., METHERINGHAM, R., POCKLEY, A.G., DURRANT, L. and MCARDLE, S., 2021. A novel HAGE/WT1-ImmunoBody® vaccine combination enhances anti-tumour responses when compared to either vaccine alone. Frontiers in Oncology, 11: 636977.

NAGARAJAN, D., PEARSON, J., BRENTVILLE, V., METHERINGHAM, R., POCKLEY, A.G., DURRANT, L. and MCARDLE, S.E., 2021. ImmunoBody®‐HAGE derived vaccine induces immunity to HAGE and delays the growth and metastasis of HAGE‐expressing tumours in vivo. Immunology and Cell Biology. ISSN 0818-9641